Dairy-Free Brand KLIMON Sponsors Competitive Eater Kobayashi
Champion ready for Netflix showdown with Chestnut: But will he save room for dessert?
Kobayashi, who has flirted with retirement from competitive eating, will go head-to-head with fellow champion Chestnut for the first time in fifteen years in the Netflix-streamed event at the HyperX Arena Las Vegas at the
"Growing up, I watched
Kobayashi's partnership with the dairy-free brand highlights the growing trend toward plant-based products in
"Concern about the environment, animal welfare and personal health are driving demand for plant-based products, particularly among younger consumers," said Cotraviwat. "At KLIMON, our motto is 'No Dairy. No Difference.' We make products so creamy and delicious; everyone enjoys them."
"After so many years in competitive eating, I'm focusing on enjoying food again – which includes leaving room for my favorite KLIMON frozen desserts," said
Tune in to watch Chestnut vs. Kobayashi: Unfinished Beef live on Netflix on
About KLIMON
KLIMON ("NO MILK" backwards) makes 100% plant-based, dairy-free products that meet today's consumer preferences with zero compromise on great taste, inspiring the brand motto "No Dairy. No Difference." KLIMON's award-winning, ultra creamy frozen desserts – made from a proprietary blend of pea protein, coconut oil and tapioca – include pints and sandwiches in more than a dozen flavors that are naturally flavored, sweetened with sugar and contain a variety of delicious mix-ins. Launched in 2022, KLIMON products are sold across the nation in grocers like Harris Teeter, Stop & Shop and Stater Brothers. For more information, visit www.klimon.com. KLIMON is a Jaback Group brand.
View original content to download multimedia:https://www.prnewswire.com/news-releases/dairy-free-brand-klimon-sponsors-competitive-eater-kobayashi-302234589.html
SOURCE KLIMON
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ramp Launches Router.com to Cut Companies' Rising AI Bills
- AuraGxP Expands Executive Leadership and Secures Initial Funding
- Vascarta Announces NIH Phase I clinical study of VAS-101 in sickle cell disease begins
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share